Conagra Brands Inc.

▲ Bull Case

• ◆R&F Volume Inflection is Real and Multi-Quarter Durable: Q3 FY26 organic volume of +3.9% is the strongest in two years; YTD R&F organic is +0.3%, positive for the first time since FY24. If sustained at +0.5% to +1.5% through FY27, the company shifts from volume decline to stability, validating the price-to-volume pivot and justifying a multiple re-rating from 9.5× to 11–12× forward P/E on $1.85 FY27 adj EPS → $20–22 price target.
• ◆Ardent Mills Stake is Materially Under-Valued; CEO Optionality Unlocks Value: The 44% equity-method JV contributes $182.4M post-tax earnings annually but is excluded from headline multiples. At a conservative 11× flour-milling multiple, the stake is worth ~$2.0–2.2B ($4–5/share). Brase, lacking legacy attachment, could pursue a monetization event (stake sale, spin-off, or restructuring) that unlocks $2–3/share of near-term value.
• ◆10.5% Dividend Yield Provides Return Floor; Modest Re-Rating Adds Upside: The current $1.40/share dividend on $13.15 stock yields 10.5% and is mathematically defensible even under stress-case FY26 EPS of $1.65 (coverage 1.18×). Combined with modest multiple expansion (+10–15% on CEO success) and a 24-month hold, a compounded 18–25% total return is achievable.

▼ Bear Case

• ◆Dividend Cut is Quantitatively Likely; Triggers Forced Selling and Multiple Compression: FY26 adj EPS guided to $1.70 with coverage of 1.21×—uncomfortably thin by rating-agency standards (IG threshold ~1.5×). If FY26 EPS prints at $1.50–1.60, coverage falls to 1.07–0.95×, forcing a dividend cut from $1.40 to $1.00–1.20. A cut would trigger forced selling by yield-mandate funds and multiple compression from 9.5× to 7.5–8.0×, resulting in -30–40% downside to $9–11.
• ◆G&S Segment Continues to Bleed Volume; Structural Not Cyclical: While R&F is +3.9% (Q3), Grocery & Snacks is -2.2% YTD and -2.2% Q3. G&S is 42% of total revenue; deterioration due to private-label competition, GLP-1 demand shift, and consumer downtrading could revert corporate organic growth to -2–3% and compound margin pressure. The Birds Eye brand impairment in Q2 FY26 signals tier-1 brands have lost pricing power.
• ◆Goodwill Overhang Persists; Next Impairment in FY27 Likely: The R&F unit carries $4.1B in remaining goodwill after the Q2 FY26 $771M impairment. If Q4 FY26 R&F volume disappoints or FY27 adj EBITDA falls below $1.75B, the end-of-FY27 impairment test will trigger a $300–500M charge, cratering FY27 adj EPS and extending the deleveraging cycle by 12+ months.

“The Central Question: Is Q3 FY26's +3.9% R&F Organic Volume an Inflection or a Bounce? Bull thesis (25% Street probability): Market-share recovery is real; price-to-volume pivot gaining traction; FY27 organic +1–2% achievable; margin recovery to 26% gross / 12% operating justified. Base thesis (50% Street probability): Q4 FY26 and Q1 FY27 show organic returning to flat-to-negative as easy comparisons lap and G&S deteriorates. Dividends hold at $1.40 (barely); leverage stays at 3.7–3.8×; stock drifts to $15–16 range. Bear thesis (25% Street probability): G&S volume remains negative; R&F momentum fades; FY26 EPS at $1.55–1.65; dividend cut to $1.00–1.20 within 12 months. Asymmetry: Bull case has concentrated upside (+$4–6/share near-term on Ardent Mills monetization signal) but requires multiple dominoes. Bear case is spread across multiple quantifiable paths (dividend cut, impairment, secular volume loss) and is perhaps 30–40% probable rather than the Street's 25%.”

• ◆CEO Transition & Strategic Reset Signal (June 1–July 15, 2026): John Brase assumes CEO role; first earnings call will signal portfolio rationalization, impairment policy, and intent on Ardent Mills. Announcement of divestiture study or Ardent Mills review catalyzes +$2–3/share upside.
• ◆Q4 FY26 Earnings & FY27 Guidance (Mid-July 2026): Full-year FY26 adj EPS and Q4 organic growth validate or invalidate R&F inflection thesis. EPS at $1.70+ with organic +1%+ shifts odds toward bull/base. EPS at $1.55–1.65 with flat organic triggers bear case.
• ◆FY27 Q1 Results & Brase's First Full-Quarter Momentum (October 2026): If R&F is positive again and G&S stabilizes, base-case trajectory gains confidence. If both turn negative, dividend-cut bear case crystallizes.
• ◆CAGNY Industry Conference (February 2027): CEO Brase presents to institutional investors. Any announcement of divestitures, buybacks, or Ardent Mills monetization catalyzes +$3–5/share move.
• ◆FY27 Q4 Results & FY28 Guidance (Summer 2027): Full-year FY27 adj EPS and margin performance. If earnings hit $2.00+ and leverage falls to 3.3× or below, stock re-rates to 11–12× P/E and reaches $22–24.

• ◆Dividend Cut (HIGH severity, 30–40% probability): Trigger = FY26 adj EPS <$1.65 OR FY27 FCF coverage <0.9×. Impact: -25–35% immediate; triggers yield-mandate fund selling; extends deleveraging cycle.
• ◆Further Goodwill Impairment (HIGH severity, 25–35% probability): Trigger = Q4 FY26 or Q1 FY27 R&F volume disappoints OR EBITDA <$1.75B. Impact: -$1–2/share earnings impact; extends deleveraging 12 months; next impairment likely if EBITDA trends weak in FY27.
• ◆GLP-1 Acceleration (MEDIUM severity, 20–30% probability): Trigger = Adoption >25M users by end-2026 OR >30% calorie reduction. Impact: -1–2% organic growth; frozen-meal segment disproportionately impacted; category tailwinds reverse.
• ◆Rating Agency Downgrade to BB+ (MEDIUM-HIGH severity, 15–25% probability): Trigger = Leverage >3.9× for 2 consecutive quarters OR FCF deteriorates further. Impact: +50–100 bps refinancing cost; unsustainable dividend; multiple compression.
• ◆Private-Label Share Acceleration (MEDIUM severity, 30–40% probability): Trigger = Great Value / Kirkland gain >150 bps/year in G&S. Impact: -50–100 bps margin pressure annually; terminal assumptions erode; organic growth reverts negative.